We describe a protocol for microinjection of embryos for an emerging model system, the cnidarian sea anemone, Nematostella vectensis. In addition, we provide protocols for carrying out overexpression and knockdown of gene function through microinjection of in vitro-translated mrnas or gene-specific oligonucleotide morpholinos (Mos), respectively. our approach is simple, and it takes advantage of the natural adherence properties of the early embryo to position them in a single layer on a polystyrene dish. embryos are visualized on a dissecting microscope equipped with epifluorescence and injected with microinjection needles using a picospritzer forced-air injection system. a micromanipulator is used to guide the needle to impale individual embryos. Injection takes ~1.5 h, and an experienced researcher can inject ~2,000 embryos in a single session. With the availability of the published Nematostella genome, the entire protocol, including cloning and transcription of mrnas, can be carried out in ~1 week.
IntroDuctIon
The starlet sea anemone, N. vectensis, is a morphologically simple basally branching animal that has a surprisingly complex genome 1 . For example, the molecular complexity that is thought to have evolved in the vertebrate lineage, such as an entire complement of wnt genes 2 and the basic genomic architecture 1 , appears to predate the cnidarian (e.g., corals, hydra, anemones and jellyfish) and bilaterian (e.g., insects and vertebrates) split 1, 2 . Its phylogenetic position and molecular complexity make Nematostella an attractive system for investigating the evolution of mechanisms that regulate animal development. Nematostella is also highly regenerative, capable of regenerating all adult structures after bisection 3, 4 . These properties make Nematostella an important animal model for investigating the relationship between the mechanisms that regulate development and regeneration of distinct cell types. In contrast, other models for investigating regeneration (planarians and Hydra) do not reproduce sexually or generate few embryos, making them less desirable for such comparisons. Vertebrate models are well suited for investigating development, but they often show limited regenerative capacity as adults and are expensive to maintain in culture. Taken together, these considerations provide compelling reasons to further develop the inexpensive invertebrate Nematostella for functional genetic investigation.
Microinjection of molecules into zygotes is one of the simplest methods for introducing RNA, DNA, protein, MOs and vital dyes into living embryos. The large egg size (200-300 µm; ref. 5 ) and accessibility to large numbers of eggs (100-1,000 per female) 6 of Nematostella make microinjection in anemone embryos a fairly straightforward and powerful approach. There are a number of techniques for microinjection that rely on magnification and stabilization of the egg or zygote, a method to manipulate an injection needle in order to bring the embryo and needle into alignment, and the ability to visualize the injection of fluid into the egg. Standard dissecting scopes provide sufficient magnification for injecting the majority of the embryo types typically used in the laboratory including Nematostella (Fig. 1) . Methods for stabilizing the embryo range from using a suction capillary tube 7 , constructing wells for holding the embryos (http://zfin.org/zf_info/zfbook/chapt5/5.1.html) or physical adherence to a substrate 8 . Nematostella embryos can be stabilized using a suction capillary. However, Nematostella embryos transiently adhere to polystyrene Petri dishes, making this a simpler alternative approach to stabilizing embryos for injection (Fig. 1b) . Visualization of the injectant entering an embryo is often achieved by co-injection with a tracer dye (e.g., a fluorescent dextran, Fast Green or phenol red). The size and opacity created by the high yolk content of Nematostella embryos make assessing the volume of fluid injected by using Fast Green and phenol red difficult. Thus, co-injection with a fluorescent tracer dye using an epifluorescence dissecting scope is the preferred method.
Misexpression of genes can be accomplished through microinjection of in vitro-synthesized mRNA coding for a gene of interest [9] [10] [11] . This approach has been used in a variety of organisms ranging from invertebrates such as Drosophila 12 to vertebrates such as Xenopus 13 . The injection of mRNA into the fertilized embryo results in ubiquitous expression of the injected mRNA (Fig. 2) , enabling researchers to assess the ability of the injected gene to affect a particular biological process. Recent papers have demonstrated the use of mRNA injection in Nematostella embryos to investigate the result of overexpressing a neurogenic gene 9 , to investigate the result of overexpressing truncated or dominant functioning forms of a particular gene 10, 14 and to rescue the phenotypes induced by knocking down of gene function using MO technology 9, 15 . These studies highlight the importance of mRNA injection-directed gene expression in that it improves the interpretation of MO gene knockdown experiments, and it enables researchers to misexpress a particular wild-type gene, as well as dominant-active, dominant-negative or individual domains of that gene.
MO-induced gene knockdown is an established technique for inhibiting the function of a specific gene by reducing the amount of functional protein in vivo 16 . MOs are synthetic nucleotide sequences designed to be complementary to the sequence of either a splice site (Fig. 3) or a translation start site (Fig. 3a,e ) in nascent mRNA molecules 17 . The binding of the MO to the target mRNA results in reduction of the protein encoded by the targeted gene. The use of MOs is distinct from other reverse genetic approaches (e.g., RNAi) because no additional cellular mechanisms are required to affect gene knockdown. In addition, when coupled with mRNA injection, it is possible to introduce gene products not targeted by the MO (Fig. 3c ) and thus to identify phenotypes specifically induced by the knockdown of a particular gene versus off-target phenotypes. Our laboratory described the first successful use of MO technology in Nematostella, wherein a splice-blocking MO was shown to inhibit proper splicing of an endogenous transcript 18 , and the first morphant phenotype using a translation-blocking MO was described the following year 19 . MO-knockdown approaches have been a valuable technique deployed consistently since that time 9, 14, 15, [19] [20] [21] [22] [23] .
In Nematostella, microinjection has been used to introduce a wide range of biological molecules and vital dyes 9, 10, 18 . Here we provide the protocol we use for microinjection of mRNA or MO molecules into the Nematostella embryo 9, 10, 14, 18, 24 . Of note, this method has recently been used to introduce reporter gene DNA into Nematostella, in some cases resulting in stable transgenic animals 25 . Regardless of the molecule being injected, the approach is essentially the same. Briefly, embryos are dejellied and maintained in sterile artificial seawater (ASW). Embryos are then adhered to a plastic surface and injected using a forced-air injection system and micromanipulator. Finally, embryos are allowed to recover and develop to the desired stage.
Experimental design
Microinjection. To microinject Nematostella eggs, zygotes or embryos, adult animals must be prepared for spawning in the evening before the day of injection 26, 27 . Ideally, male and female anemones are in separate bowls so that the researcher can control the timing of fertilization. However, male and female gametes show reduced fertility by 2 h after spawning occurs 27 . After animals have spawned and fertilization has taken place, the eggs are dejellied using a 4% (wt/vol) cysteine solution 27 and washed in sterile 1/3× ASW. Embryos are then transiently adhered to polystyrene dishes in sterile 1/3× ASW and injected with the desired solution. If minimally disturbed, embryos will remain adherent to polystyrene dishes for ~3-4 h. First cleavage of Nematostella embryos occurs 1-2 h after fertilization, depending on the temperature 5, 10, 27 , thereby providing sufficient time to carry out the injection protocol before the loss of adherence. Maintaining a cool (~17 °C) injection room slightly extends the time to first cleavage, which allows additional time for injection. If fluorescent dyes are used as co-injectants, as we recommend, injection rigs should be set up in a room in which the lights can be dimmed to improve visualization of tracer dye, which increases the ability to control the volume of material injected. With ~2 h between fertilization and first cleavage, an efficient researcher can dejelly and wash embryos in 30 min, leaving 1.5 h for injection. In 1.5 h, between 700 and 2,000 embryos can be injected, depending on the experience of the researcher.
A key for rapid and successful microinjection is the preparation of suitable injection needles. There are several commercial options for instruments to fashion glass micropipettes. Each instrument has parameters that can be varied to influence the tip size, taper length and so on. In addition, there are different kinds of glass that can be used (e.g., borosilicate or aluminosilicate), which influence the characteristics of the injection pipette. Some researchers prefer shorter, stiffer pipettes (Fig. 1c, left needle) , whereas others prefer longer, more flexible tips that can be broken back in case of tip clogging (Fig. 1c, right needle) . Figure 1c provides a range of suitable needles for the injection of Nematostella; in Equipment Setup, we provide details on setting variables on the Sutter pipette puller. mRNA microinjection. To inject mRNA into any animal, including Nematostella, one must first generate and isolate the mRNA molecule of interest. The coding region of a gene of interest is identified and subcloned into a vector designed for in vitro mRNA transcription, typically such that a fluorescent fusion protein is generated or such that the protein encoded by the mRNA can be visualized with a commercially available antibody (anti-FLAG, HA, GST and so on). When choosing possible tags and their positions, it is important to consider the basic organization of conserved domains in the protein encoded by the mRNA. In general, it is best to subclone the cDNA so that possible tags are as far as possible from functional domains. For instance, if a conserved domain exists toward the C terminus of your protein, then generating an N-terminal tag is less likely to cause unexpected effects on protein function. It is important to remember that although fusion proteins can usually be used without issue, there is the possibility that a fusion protein will behave differently than its wild-type untagged counterpart. After designing and subcloning, mRNA is generated by in vitro transcription and purified before injection into zygotes. There are a number of kits and methods available for purifying mRNA. However, we find that using the protocol described below leads to reliable and stable expression in vivo, and thus we prefer it to other methods. For each functional experiment, an appropriate effective concentration of mRNA must be determined for each gene (Box 1). In our hands, most effective mRNA concentrations fall within the range of 150-700 ng µl − 1 . To determine the appropriate concentration, it is useful to monitor injected embryos to determine whether they are viable and for expression of the protein of interest. mRNA concentrations that are too high are toxic to the embryo. The toxic effect can induce death even before any cleavages are observed. This is indicated by a breakdown in cell membrane and the release of cytoplasmic contents. Embryos may also go through a number of cleavages before failing. In this case, cells fail to adhere to one another and late-cleavage stage embryos disassociate. One issue is that the overexpression of mRNA may cause a lethal phenotype but not because of toxicity. One control for determining whether the overexpression of mRNA induces nonspecific toxicity is to co-inject the mRNA and an MO designed to block translation of that mRNA. This experiment should rescue lethal phenotypes induced by the overexpression of the protein encoded by the mRNA in question. Concentrations of mRNA that are too low are more difficult to determine; however, the inability to detect the fluorescent fusion protein, which is properly cloned in-frame, is a good indicator that mRNA levels are too low. Protein detection can be observed either directly with fluorescence imaging when using a fluorescently tagged protein (Fig. 2) or by immunofluorescence if an antibody exists against your protein of interest or if you have cloned your mRNA in-frame with a tag against which a commercial antibody exists (e.g., FLAG, HA, GST and so on). Animals injected with the optimal concentration of mRNA are sorted on the basis of the presence of the protein product encoded by the injected mRNA (usually as judged by expression of the fused fluorescent tag). Nuclear localization is expected because the venus coding sequence is fused in-frame with the NvashA transcription factor coding sequence, which contains a nuclear localization signal. (e-l) Low magnification views of unsorted embryos grown at 17 °C for 24 h after injection. Embryos were co-injected with dextran and NvashA:venus mRNA (e-h) or dextran alone (i-l). Nearly all embryos co-injected with the dextran and mRNA show strong fluorescence from the Venus protein (g,h), whereas control animals do not show green fluorescence (k,l). DIC, differential interference contrast. Scale bars (a-d), 100 µm; (e-l), 500 µm. Once proper concentration has been determined, perform future experiments using the optimized concentration of mRNA and allow embryos to proceed to the desired developmental stage for phenotypic analysis. Injection controls include the following: (i) inject fluorescent dextran alone (eliminates possible phenotypes induced by the act of injection); (ii) inject an mRNA that encodes a protein that should not affect the biological process of interest, such as fluorescent protein alone (this eliminates the possibility that the fluorescent tag or translation load owing to foreign mRNA is the source of the phenotype); and (iii) conduct a rescue experiment by co-injecting a translation-blocking MO that specifically recognizes the mRNA to ensure that the phenotypes resulting from injection are specifically due to the overexpression of the gene of interest.
MO microinjection. MO-based gene knockdown is carried out using essentially the same protocol as is used for mRNA gene misexpression. Splice-or translation-blocking MOs are designed against a gene of interest with the help of the GeneTools MO design team (https://oligodesign.gene-tools.com/request/). MOs can be fluorescently labeled after production or co-injected with a vital fluorescent dye (which is a less expensive alternative to MO after modification). As with mRNA injections, the appropriate concentration of MO must be determined before conducting the experiment (Box 1). A general approach is to use a series of MO concentrations ranging from 100 to 1,000 µM. Determine possible toxicity induced by the injection of each concentration of MO as described above for mRNA. The efficacy of the MO must also be determined so that the extent of gene knockdown can be assessed. If you are using a splice-blocking MO, collect RNA from injected animals and controls. Thereafter, generate cDNA and determine the ratio of spliced versus mis-spliced target transcript present in the cDNA by RT-PCR ( Fig. 3f; refs. 14, 15, 19) . To demonstrate the effectiveness of a translation-blocking MO, perform western blotting using an antibody against the protein encoded by the target transcript 23 , co-inject an mRNA recognized by the MO fused to a fluorescent protein (Fig. 3e) or perform an in vitro translation assay 15, 19 . However, only quantification of endogenous protein levels encoded by the targeted mRNA can determine the true efficacy of the MO. The goal is to define the lowest concentration of MO that provides the most complete knockdown of the gene of interest.
Once the proper concentration of MOs is determined, perform future experiments with the optimized concentration and allow animals to age to the desired developmental stage for phenotypic analysis. MO knockdown may not completely eliminate gene function, and splice variants inadvertently generated with a splice MO 16 may have phenotypes that are inconsistent with reduced gene function; thus, when possible, it is desirable to design two MOs against the same gene to ensure that similar phenotypes are obtained when each MO is injected individually. Control experiments are critical to properly interpret phenotypes induced by MO gene knockdown 28 . Controls to inject are the following: a control MO (often a similar MO to the experimental MO that contains five mismatches) and a rescue experiment in which an mRNA is co-injected that codes for a functional protein but is not recognized by the MO (to ensure that the phenotypes are specific to the knockdown of the anticipated target and not due to off-target effects of MO injection) (Fig. 3a-e) .
Box 1 | Optimizing
of the main PROCEDURE to inject 100-300 embryos with each concentration of mRNA or MO to be tested. For most genes an mRNA concentration range of 150, 250 and 500 ng µl − 1 , and an MO concentration range of 300-900 µM will be suitable for determining an effective concentration at which to carry out subsequent experiments. 2. Incubate embryos after injection and score them at ~4 and 24 h after injection for toxicity and effectiveness of injected reagent as described below.
? trouBlesHootInG scoring for toxicity Toxicity is usually associated with high concentrations of mRNA or MO, and it is usually evident by death and/or failed cleavage of the embryo. Death induces a breakdown in cell membrane and the release of cytoplasmic contents. Embryos may go through a number of cleavages before death, but cells eventually fail to adhere to one another and late-cleavage stage embryos will dissociate. scoring for effectiveness of injectant Scoring for effectiveness of injected mRNA is most easily achieved by cloning the gene of interest in frame with a detectable fluorescent tag (e.g., GFP, RFP or Venus; Fig. 2) . Detection of the fluorescent tag indicates that mRNA levels are sufficiently high to result in detectable translated protein. Alternatively, if an antibody exists against the protein encoded by the mRNA or a commercially available tag included in the mRNA coding sequence (e.g., FLAG, HA, GST), immunofluorescence or western blotting could be used to show an increase in protein levels after injection of the mRNA. There are multiple ways to determine whether MO injections are effective at achieving gene knockdown. The ideal method for determining effectiveness of both translation-and splice-blocking MOs is to perform a western blot analysis using an antibody that recognizes the endogenous target protein. This approach allows the quantification of the reduction of protein levels between experimental and control groups. However, if no antibody exists, translation-blocking MO can be tested by co-injection of an mRNA encoding for the target gene that is fused to a fluorescent tag and is recognized by the MO. Loss or reduced fluorescence compared with injection of the mRNA alone indicates effective MO knockdown (Fig. 3e) . Alternatively, you can perform an in vitro translation assay to show that the presence of MO inhibits the translation of the mRNA recognized by the MO 15, 19 . It should be noted that these two approaches do not identify how effective a MO is at inhibiting the translation of endogenous transcripts, but they provide some indication that the MO is blocking translation. Splice-blocking MO effectiveness can be assayed by performing RT-PCR on cDNA generated from RNA extracted from MO-injected and control animals. This allows for a quantification of the relative abundance of properly to improperly spliced transcripts in both the control and MO-injected animals (Fig. 3f) After pulling, store glass needles upright with the tips pointed down in an electrode storage jar. Microinjection rig setup To perform microinjections under a dissecting scope, it is optimal to have the injection needle appear in the middle of the visual field of the microscope and to bring the cells to be injected to the tip of the needle. The oil-filled hydraulic joystick micromanipulator has a limited range that the researcher uses for the final impalement of the cell. The hydraulic manipulator is also attached to a coarse manipulator that is used to position the needle in the center of the field at the onset of each injection session. Take care not to damage the hydraulic oil-filled tubing that links the micromanipulator needle holder support to the joystick. The glass injection pipette is held in a stainless steel holder that is mounted to the hydraulic manipulator ( Fig. 1a and Supplementary Fig. 1 ). The stainless steel pipette holder is attached to the picospritzer by 1-mm tubing to the 'p-out' adaptor on the front of the instrument (provided by the manufacturer). The picospritzer is a device that uses gas (normally air) pressure to force fluid through the micropipette. The Harvard apparatus picospritzer requires an external air compressor that enters the instrument through the 'p-in' valve on the back of the instrument with non-expandable thick-walled 1/8-inch tubing (provided by the manufacturer).
The injection micropipette is placed in the open end of the holder, through the internal o-ring, and the end piece is tightened gently by hand. The stainless steel holder is then mounted on the hydraulic manipulator. The volume of material injected is controlled largely by the amount of pressure released and the duration of release on the picospritzer. Typical pressure values are 5-25 psi over times of 10-30 ms. Actuation of each injection event is generally performed using a foot pedal, allowing one hand free to position the dish of embryos at the tip of the injection pipette, and the other hand to operate the hydraulic joystick manipulator. proceDure preparation of mrna or Mos for microinjection 1| A number of different molecules can be injected into Nematostella embryos. Here we provide details for preparing mRNA (option A) or MOs (option B) for microinjection.
(a) preparation of mrna for microinjection • tIMInG ~7-10 d  crItIcal The cDNA of interest must be subcloned into a vector suitable for in vitro transcription before beginning this protocol. The vector choice and subcloning strategy can be carried out by conventional recombinant DNA techniques that are not described here. We use the pCS2:GFP plasmid 11 and the Gateway pSPE3 system 29 9| Load each needle with 0.5 µl of injection cocktail.  crItIcal step Do not overload the needle with liquid. The cocktail will travel to the tip of the needle via capillary action in 1-3 min.
10| Scratch the bottom of a plastic Petri dish (60 × 15 mm) with forceps to form a series of parallel scratches spaced ~0.5 cm apart (Fig. 1b) .  crItIcal step Use the recommended Petri dishes to ensure suitable adherence of the embryos to the dish during injection.
11|
Add enough filtered 1/3× ASW to cover the bottom of the scratched Petri dish but not too much to interfere with clear visibility during the injection protocol.  crItIcal step Add water immediately before adding embryos. Embryo adherence decreases if water rests in the dish before the addition of embryos.
12| By using a Pasteur pipette, transfer the desired number of embryos in single lines between and parallel to the scratches (Fig. 1b) .
? trouBlesHootInG 13| Insert a pulled needle into the picospritzer needle holder.
14|
Adjust the needle so that it is centered in the field of view through the oculars at lowest magnification.  crItIcal step Keep the needle at a steep (≥45° angle). This angle is ideal for the injecting process. Lower angles can result in the embryos being pushed around rather than being pierced by the needle.
15|
Slowly lower the needle and locate the tip as it breaks the surface of the water.
16|
Increase the magnification and lower the needle to the bottom of the dish.
17|
Break the tip of the needle by using the micromanipulator to tap the needle against the bottom of the dish or against the side of the scratches. Set the balance pressure on the picospritzer such that the dye is barely flowing out of the tip of the needle. ? trouBlesHootInG 18| By using fluorescent dye as a tracer, adjust the pressure and time on the picospritzer so that a single pulse will fill ~3-5% of the embryo volume estimated by eye using the small sphere present immediately after a pulse is injected and before the tracer dye begins to diffuse. This is equivalent to ~10 pl. Estimating by eye is easier than measuring the volume, as adjustments often need to be made during injection to cope with issues such as decreased flow when the needle clogs slightly or increased flow when the tip breaks slightly during injection. ? trouBlesHootInG 19| By using the micromanipulator, insert the needle just inside the top surface of each embryo, and inject each embryo with a single pulse.
20|
Inject a second dish of embryos with appropriate control(s).
21|
Transfer the embryos to the desired incubation temperature, although it may be best to leave the embryos at cooler temperatures (17 °C) for 2-4 h before moving them to a warmer final temperature (typically 22 °C). Determine the success of the injection by determining whether injected animals are cleaving and are not dying, which can be indicated by loss of cell adhesion and the apparent disintegration of embryos. 
22|

• tIMInG
Step 1A(i-xvi), preparing template for transcription reaction: ~7 d to subclone
Step 1A(xvii-xxi), in vitro transcription reaction: ~2 h
Step 1A(xxii-xlviii), mRNA purification: ~3 h
Step 1A(xlix), preparing microinjection cocktails: ~1 h
Step 1B(i,ii), preparation of MO: ~30 min
Step 1B(iii), preparation of injection mix: ~30 min Steps 2-6, embryo preparation: ~1 h Steps 6-13, microinjection apparatus setup: ~5-15 min Steps 14-22, microinjection: ~1-2 h Box 1, optimizing mRNA or MO concentration for microinjection: ~1 d
antIcIpateD results
Microinjection
On average, 90% of embryos survive the injection procedure and appear normal at 24 h after injection (Fig. 4a) . However, this is variable and can range from 85 to 95% (Fig. 4a) . More importantly, the percentage of embryos from uninjected controls that survive the first 24 h is similar to that observed for animals injected with MO, mRNA or dextran (Fig. 4a) , suggesting that injection alone does not markedly disrupt animal development. After the first 24 h, survival stabilizes and animals develop normally. On average, 90% of the uninjected controls present at 24 h form normal four-tentacle juvenile polyps by day 6. We observe similar numbers of development for dextran-, mRNA-or MO-injected animals ( Fig. 4b) , suggesting that major disruptions to development are not induced by the injection of dye alone, of control MO or of mRNA encoding GFP. Taken together, these data show that Nematostella development is robust and not substantially affected after the injection of control molecules.
mrna injection
Typically, more than 95% of surviving injected embryos show protein expression after mRNA injection (Fig. 2g) . Fluorescence of the expressed protein from venus mRNA is routinely detected ~2 h after injection and subcellular localization of the protein of interest can also be detected early ( Fig. 2a-d) . Fluorescence after mRNA injection can be observed at least 1 week after the injection (supplementary Fig. 2) . The overall stability of the mRNA and the translated protein are variable depending on the mechanisms acting to regulate each gene during development. For example, NvashA:venus (Fig. 2) The relative amount of knockdown is insufficient to produce a phenotype Design additional MOs against the same target gene and co-inject multiple MOs to increase gene knockdown fertilization in animals grown at 25 °C as observed on a dissecting scope, whereas injection of an unfused gfp coding sequence could still be detected 6 d after injection (supplementary Fig. 1 ).
Mo injection
As with mRNA injection, ~90% of the animals survive the injection protocol after MO injection. The benefit of MOs is that they are stable and do not degrade after injection. Reports have described morphant phenotypes in animals over 10 d old 19 . Quantification of the MO efficacy is crucial in some cases, as phenotypes are typically hypomorphic rather than the amorphic phenotypes associated with genetic null alleles. For example, with a splice-blocking MO, it is typical to be able to detect the presence of wild-type mRNA by RT-PCR ( Fig. 3f; refs. 14,18,19 ).
